BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BMS-986460 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BMS-986460\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06067841-11179@assetmemo.bio
DTSTAMP:20261121T005556Z
DTSTART;VALUE=DATE:20290824
DTEND;VALUE=DATE:20290825
SUMMARY:BMS-986460: Phase 1 readout est. (NCT06067841)
DESCRIPTION:BMS-986460\, phase 1\, Prostate Cancer.\nStudy: A Study to Asse
 ss BMS-986460 in Participants With Metastatic Castration-resistant Prostat
 e Cancer\nEstimated primary completion: 24 August 2029. This is a Clinical
 Trials.gov estimate\, not a confirmed readout date\, and it can move.\nDru
 g page: https://assetmemo.bio/drug/bms-986460#upcoming-events\nRegistry re
 cord: https://clinicaltrials.gov/study/NCT06067841
URL:https://assetmemo.bio/drug/bms-986460#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
